These differences are strictly within the regulatory standards of each respective country (FDA in the U.S., COFEPRIS in Mexico, and Health Canada in Canada)
In addition to quieting that food noise, these types of weight loss medications can actually reduce heart disease, that might be independent of weight loss, in addition to improvements in heart function and functional status in individuals with heart failure. The medication is also currently being studied for how it can target symptoms of kidney disease and Alzheimers
Telehealth-Only Clinics Prescription based on online questionnaire No baseline or follow-up body composition data No bloodwork monitoring during treatment Scale weight as only metric of progress No protocol for muscle preservation Limited ability to detect or manage side effects Moonshot Medical Approach In-person evaluation with comprehensive bloodwork Baseline and follow-up DEXA body composition scans Regular metabolic panel monitoring (liver, kidney, thyroid, lipids) Fat loss vs
More recent findings confirm these effects, although effect sizes are typically small and the evidence base remains heterogeneous [96]
Can I skip doses or pause my titration